Lamivudine is not effective in primary Sjögren's syndrome

Annals of the Rheumatic Diseases

Volumn 64, Issue 9, 2005, Pages 1326-1330

  Gescuk, B ^a   Wu, A J ^a   Whitcher, J P ^a   Daniels, T E ^a   Lund, S ^a   Fye, K ^a   Davis Jr , John C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYCHLOROQUINE; LAMIVUDINE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; LACRIMAL GLAND FUNCTION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SALIVARY GLAND BIOPSY; SALIVARY GLAND FUNCTION; SJOEGREN SYNDROME; TREATMENT FAILURE;

ADULT; BIOPSY; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LAMIVUDINE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE INHIBITORS; SALIVARY GLANDS, MINOR; SALIVATION; SEVERITY OF ILLNESS INDEX; SJOGREN'S SYNDROME; TEARS; TREATMENT FAILURE;

EID: 23944490408     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2004.031393     Document Type: Article

References (64)

1. Hedfors E, Lindahl G. Variation of MHC class I and II antigen expression in relation to lymphocytic infiltrates and interferon-gamma positive cells. J Rheumatol 1990;17:743-50.
2. Fox RI, Bumol T, Fantozzi R, Bone R, Schreiber R. Expression of histocompatibility antigen HLA-DR by salivary gland epithelial cells in Sjogren's syndrome. Arthritis Rheum 1986;29:1105-11.
3. Lindahl G, Hedfors E, Klareskog L, Forsum U. Epithelial HLA-DR expression and T lymphocyte subsets in salivary glands in Sjogren's syndrome. Clin Exp Immunol 1985;61:475-82.
4. Adamson TC, Fox RI, Frisman DM, Howell FV. Immunohistologic analysis of lymphoid infiltrates in primary Sjogren's syndrome using monoclonal antibodies. J Immunol 1983;130:203-8.
5. Zumla A, Mathur M, Stewart J, Wilkinson L, Isenberg D. T cell receptor expression in Sjogren's syndrome. Ann Rheum Dis 1991;50:691-3.
6. Anaya JM, Correa PA, Mantilla RD, Arcos-Burgos M. TAP, HLA-DQB1, and HLA-DRB1 polymorphism in Colombian patients with primary Sjogren's syndrome. Semin Arthritis Rheum 2002;31:396-405.
7. Gottenberg JE, Busson M, Loiseau P, Cohen-Solal J, Lepage V, Charron D, et al. In primary Sjogren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response. Arthritis Rheum 2003;48:2240-5.
8. Guggenbuhl P, Jean S, Jego P, Grosbois B, Chales G, Semana G, et al. Primary Sjogren's syndrome: role of the HLA-DRB1*0301-*501 heterozygotes. J Rheumatol 1998;25:900-5.
9. Hay EM, Thomas E, Pal B, Hajeer A, Chambers H, Silman AJ. Weak association between subjective symptoms or and objective testing for dry eyes and dry mouth: results from a population based study. Ann Rheum Dis 1998;57:20-4.
10. Kassan SS. Immunogenetics of Sjogren's syndrome. Ann Med Interne (Paris) 1998;149:45-8.
11. Panchovska M, Sheitanov Y, Martinova F. Locus DR in primary Sjogren's syndrome. Bratisl Lek Listy 2001;102:382.
12. Sawada S, Sugai S, Iijima S, Takei M, Paredes E, Hayama T, et al. Increased soluble CD4 and decreased soluble CD8 molecules in patients with Sjogren's syndrome. Am J Med 1992;92:134-40.
13. Tapinos NI, Polihronis M, Tzioufas AG, Skopouli FN. Immunopathology of Sjogren's syndrome. Ann Med Interne (Paris) 1998;149:17-24.
14. Yamamoto K. Pathogenesis of Sjogren's syndrome. Autoimmun Rev 2003;2:13-18.
15. Sasaki M, Nakamura S, Ohyama Y, Shinohara M, Ezaki I, Hara H, et al. Accumulation of common T cell clonotypes in the salivary glands of patients with human T lymphotropic virus type I-associated and idiopathic Sjogren's syndrome. J Immunol 2000;164:2823-31.
16. Matsumoto I, Tsubota K, Satake Y, Kita Y, Matsumura R, Murata H, et al. Common T cell receptor clonotype in lacrimal glands and labial salivary glands from patients with Sjogren's syndrome. J Clin Invest 1996;97:1969-77.
17. Sumida T, Matsumoto I, Maeda T, Nishioka K. T-cell receptor in Sjogren's syndrome. Br J Rheumatol 1997;36:622-9.
18. Couderc LJ, Libera S, Klauss V, Goebel FD. Sicca complex and infection with human immunodeficiency virus. Arch Intern Med 1987;147:898-901.
19. Vernant JC, Buisson G, Magdeleine J, De Thore J, Jouannelle A, Neisson-Vernant C, et al. T-lymphocyte alveolitis, tropical spastic paresis, and Sjogren syndrome. Lancet, 1988;i, 177.
20. Eguchi K, Matsuoka N, Ida H, Nakashima M, Sakai M, Sakito S, et al. Primary Sjogren's syndrome with antibodies to HTLV-1: clinical and laboratory features. Ann Rheum Dis 1992;51:769-76.
21. Terada K, Katamine S, Eguchi K, Moriuchi R, Kita M, Shimada H, et al. Prevalence of serum and salivary antibodies to HTLV-1 in Sjogren's syndrome. Lancet 1994;344:1116-19.
22. Tamiya S, Matsuoka M, Etoh K, Watanabe T, Kamihira S, Yamaguchi K, et al. Two types of defective human T-lymphotropic virus type I provirus in adult T-cell leukemia. Blood 1996;88:3065-73.
23. Talal N, Dauphinee MJ, Dang H, Alexander SS, Hart DJ, Garry RF. Detection of serum antibodies to retroviral proteins in patients with primary Sjogren's syndrome (autoimmune exocrinopathy). Arthritis Rheum 1990;33:774-81.
24. Yamano S, Renard JN, Mizuno F, Narita Y, Uchida Y, Higashiyama H, et al. Retrovirus in salivary glands from patients with Sjogren's syndrome. J Clin Pathol 1997;50:223-30.
25. Garry RF, Fermin CD, Hart DJ, Alexander SS, Donehower LA, Luo-Zhang H. Detection of a human intracisternal A-type retroviral particle antigenically related to HIV. Science 1990;250:1127-9.
26. Mariette X, Agbalika F, Daniel MT, Bisson M, Lagrange P, Brouet JC, et al. Detection of human T lymphotropic virus type I tax gene in salivary gland epithelium from two patients with Sjogren's syndrome. Arthritis Rheum 1993;36:1423-8.
27. Green JE, Hinrichs SH, Vogel J, Jay G. Exocrinopathy resembling Sjogren's syndrome in HTLV-1 tax transgenic mice. Nature 1989;341:72-4.
28. Steinfeld SD, Demols P, Van Vooren JP, Cogan E, Appelboom T. Zidovudine in primary Sjogren's syndrome. Rheumatology (Oxford) 1999;38:814-17.
29. Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM, et al. Preliminary criteria for the classification of Sjogren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993;36:340-7.
30. Cummins MJ, Papas A, Kammer GM, Fox PC. Treatment of primary Sjogren's syndrome with low-dose human interferon alfa administered by the oromucosal route: combined phase III results. Arthritis Rheum 2003;49:585-93.
31. Atkinson JC, Travis WD, Pillemer SR, Bermudez D, Wolff A, Fox PC. Major salivary gland function in primary Sjogren's syndrome and its relationship to clinical features. J Rheumatol 1990;17:318-22.
32. Skopouli FN, Jagiello P, Tsifetaki N, Moutsopoulos HM. Methotrexate in primary Sjogren's syndrome. Clin Exp Rheumatol 1996;14:555-8.
33. Fox RI, Robinson CA, Curd JG, Kozin F, Howell FV. Sjogren's syndrome. Proposed criteria for classification. Arthritis Rheum 1986;29:577-85.
34. Daniels TE. Labial salivary gland biopsy in Sjogren's syndrome. Assessment as a diagnostic criterion in 362 suspected cases. Arthritis Rheum 1984;27:147-56.
35. Greenspan JS, Daniels TE, Talal N, Sylvester RA. The histopathology of Sjogren's syndrome in labial salivary gland biopsies. Oral Surg Oral Med Oral Pathol 1974;37:217-29.
36. Abel U, Koch A. The role of randomization in clinical studies: myths and beliefs. J Clin Epidemiol 1999;52:487-97.
37. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 2000;342:1887-92.
38. Kruize AA, Hene RJ, Kallenberg CG, van Bijsterveld OP, van der Heide A, Kater L, et al. Hydroxychloroquine treatment for primary Sjogren's syndrome: a two year double blind crossover trial. Ann Rheum Dis 1993;52:360-4.
39. Tishler M, Yaron I, Shirazi I, Yaron M. Hydroxychloroquine treatment for primary Sjogren's syndrome: its effect on salivary and serum inflammatory markers. Ann Rheum Dis 1999;58:253-6.
40. Fox RI, Dixon R, Guarrasi V, Krubel S. Treatment of primary Sjogren's syndrome with hydroxychloroquine: a retrospective, open-label study. Lupus 1996;5(suppl 1):S31-6.
41. Manoussakis MN, Moutsopoulos HM. Antimalarials in Sjogren's syndrome - the Greek experience. Lupus 1996;5(suppl 1):S28-30.
42. Fox RI, Chan E, Benton L, Fong S, Friedlaender M, Howell FV. Treatment of primary Sjogren's syndrome with hydroxychloroquine. Am J Med 1988;85:62-7.
43. Drosos AA, Skopouli FN, Galanopoulou VK, Kitridou RC, Moutsopoulos HM. Cyclosporin a therapy in patients with primary Sjogren's syndrome: results at one year. Scand J Rheumatol Suppl 1986;61:246-9.
44. Dalavanga YA, Detrick B, Hooks JJ, Drosos AA, Moutsopoulos HM. Effect of cyclosporin A (CyA) on the immunopathological lesion of the labial minor salivary glands from patients with Sjogren's syndrome. Ann Rheum Dis 1987;46:89-92.
45. Miyawaki S, Nishiyama S, Matoba K. Efficacy of low-dose prednisolone maintenance for saliva production and serological abnormalities in patients with primary Sjogren's syndrome. Intern Med 1999;38:938-43.
46. Fox PC, Datiles M, Atkinson JC, Macynski AA, Scolt J, Fletcher D, et al. Prednisone and piroxicam for treatment of primary Sjogren's syndrome. Clin Exp Rheumatol 1993;11:149-56.
47. Steinfeld SD, Demols P, Salmon I, Kiss R, Appelboom T. Infliximab in patients with primary Sjogren's syndrome: a pilot study. Arthritis Rheum 2001;44:2371-5.
48. Mariette X, Ravaud P, Steinfeld S, Baron G, Goetz J, Hachulla E, et al. Inefficacy of infliximab in primary Sjogren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjogren's Syndrome (TRIPSS). Arthritis Rheum 2004;50:1270-6.
49. Fox RI, Saito I. Criteria for diagnosis of Sjogren's syndrome. Rheum Dis Clin North Am 1994;20:391-407.
50. Vitali C, Bombardier: S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
51. Physician Desk Reference Online. Montvale, NJ: Thomas Healthcare, 2003-4.
52. Papas AS, Fernandez MM, Castano RA, Gallagher SC, Trivedi M, Shrotriya RC. Oral pilocarpine for symptomatic relief of dry mouth and dry eyes in patients with Sjogrens syndrome. Adv Exp Med Biol 1998;438:973-8.
53. Petrone D, Condemi JJ, Fife R, Gluck O, Cohen S, Dalgin P. A double-blind, randomized, placebo-controlled study of cevimeline in Sjogren's syndrome patients with xerostomia and keratoconjunctivitis sicca. Arthritis Rheum 2002;46:748-54.
54. Fife RS, Chase WF, Dore RK, Wiesenhutter CW, Lockhart PB, Tindall E, et al. Cevimeline for the treatment of xerostomia in patients with Sjogren syndrome: a randomized trial. Arch Intern Med 2002;162:1293-300.
55. Asmussen KH, Bowman SJ. Outcome measures in Sjogren's syndrome. Rheumatology (Oxford) 2001;40:1085-8.
56. Bowman SJ. Collaborative research into outcome measures in Sjogren's syndrome. Update on disease assessment. Scand J Rheumatol Suppl 2002;(116):23-7.
57. Bowman SJ, Pillemer S, Jonsson R, Asmussen K, Vitali C, Manthorpe R, et al. Revisiting Sjogren's syndrome in the new millennium: perspectives on assessment and outcome measures. Report of a workshop held on 23 March 2000 at Oxford, UK. Rheumatology (Oxford) 2001;40:1180-8.
58. Pflugfelder SC, Tseng SC, Sanabria O, Kell H, Garcia CG, Felix C, et al. Evaluation of subjective assessments and objective diagnostic tests for diagnosing tear-film disorders known to cause ocular irritation. Cornea 1998;17:38-56.
59. Schein OD, Tielsch JM, Munoz B, Bandeen-Roche K, West S. Relation between signs and symptoms of dry eye in the elderly. A population-based perspective. Ophthalmology 1997;104:1395-401.
60. Tiplady B, Jackson SH, Maskrey VM, Swift CG. Validity and sensitivity of visual analogue scales in young and older healthy subjects. Age Ageing 1998;27:63-6.
61. Humphreys-Beher MG, Brayer J, Yamachika S, Peck AB, Jonsson R. An alternative perspective to the immune response in autoimmune exocrinopathy: induction of functional quiescence rather than destructive autoaggression. Scand J Immunol 1999;49:7-10.
62. Jonsson R, Kroneld U, Backman K, Magnusson B, Tarkowski A. Progression of sialadenitis in Sjogren's syndrome. Br J Rheumatol 1993;32:578-81.
63. Leroy JP, Pennec YL, Soulier C, Berthelot JM, Letoux G, Youinou P. Follow up study of labial salivary gland lesions in primary Sjogren's syndrome. Ann Rheum Dis 1992;51:777-80.
64. Rostron J, Rogers S, Longman L, Kaney S, Field EA. Health-related quality of life in patients with primary Sjogren's syndrome and xerostomia: a comparative study. Gerodontology 2002;19:53-9.